Harnessing glucose metabolism with nanomedicine for cancer treatment
Theranostics · 2024 · 14 (17) · 6831-6882
DOI: 10.7150/thno.100036 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, 2024. Verfasst von Xudong Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Vaccine & Serum Institute (NVSI), China National Biotech Group (CNBG), Sinopharm Group, No. 38 Jing Hai Second Road, Beijing 101111, China. Hauptthemen laut MEDLINE: Neoplasms, Glucose, Nanomedicine. Die Arbeit wurde bisher 57-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Vaccine & Serum Institute (NVSI), China National Biotech Group (CNBG), Sinopharm Group, No. 38 Jing Hai Second Road, Beijing 101111, China.
- School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211195, China.
- China National Pharmaceutical Group Co Ltd., Sinopharm Plaza, No 20 Zhichun Road, Haidian district, Beijing 100191, China.
- Department of Respiratory and Critical Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 211100, China.
Zitieren
APA
Wang, X., Wang, L., Hao, Q., Cai, M., Wang, X., & An, W. (2024). Harnessing glucose metabolism with nanomedicine for cancer treatment. Theranostics, 14(17), 6831-6882. https://doi.org/10.7150/thno.100036
Vancouver
Wang X, Wang L, Hao Q, Cai M, Wang X, An W. Harnessing glucose metabolism with nanomedicine for cancer treatment. Theranostics. 2024;14(17):6831-6882. doi:10.7150/thno.100036
BibTeX
@article{Wang2024,
author = {Wang, Xudong and Wang, Liping and Hao, Qingyi and Cai, Meng and Wang, Xueting and An, Wenlin},
title = {Harnessing glucose metabolism with nanomedicine for cancer treatment},
journal = {Theranostics},
year = {2024},
volume = {14},
number = {17},
pages = {6831--6882},
doi = {10.7150/thno.100036}
}
EUVIMED